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CONTRADICTORY ACTIONS OF CAFFEINE, CORAMINE, AND 
METRAZOL. By A rnold H amilton Malo n ey , Ph.D., M.D. 
From the Department of Pharmacology, Howard University 
School of Medicine, Washington, D.C.
(Received for publication 30th March 1935.)
In 1929, while engaged in the study which revealed the reciprocal 
antagonism of picrotoxin and the barbiturates, we observed that under 
certain conditions such stimulants as strychnine and coramine [Maloney, 
Fitch, and Tatum, 1931] seemed to hasten the fatal termination of the 
animal poisoned with a lethal dose of one of the barbiturates. Since 
strychnine is known to exert both a stimulant and a depressant action 
the question arose as to whether other convulsants might not also be 
possessed of contradictory actions. In the following experiments we 
have subjected coramine, metrazol, and caffeine to certain tests for this 
possible dualism.
Method of Approach.— A surely lethal dose of caffeine administered 
subcutaneously to a normal rat elicits a state of severe apprehensive­
ness, grossly exaggerated tremors, a staggering gait, and distressed 
breathing. These phenomena may endure for an hour or more and 
the animal passes gradually into a state of depression in which he 
lingers until death finally ensues. Coramine and metrazol, on the 
other hand, when administered in surely lethal doses are followed by 
genuine convulsions. The terminal event, usually respiratory in 
character, is generally described as an asphyxia due to one or more 
of the following causes : tetany of the muscles of respiration, paralysis 
of the respiratory centre, and general exhaustion—a state which when 
protracted may present the appearance of a genuine condition of 
depression. When the animal is in an initial state of depression the 
role of a stimulant agent can more decisively be determined as to its 
antagonistic or its possible potentiative action. Since, in medical 
practice, stimulatory action is the prime desideratum in depressed 
states, laboratory investigation of the role played by stimulant drugs 
is best made upon animals in an experimentally-induced state of 
depression.
In our experiments the animals were narcotised with a sub-lethal 
dose of barbital sodium (medinal). Mature stock rats and rabbits 
were employed.
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Our method was to administer a sub-lethal but narcotising dose of 
barbital [Fitch and Tatum, 1932, found the M.L.D. of barbital to be 
300 mg./kg. for the rat and 225 mg./kg. for the rabbit, both intraperi- 
toneally], and follow this with doses of the stimulant ranging from 
a stimulating to a lethal amount at the onset of narcosis. Preliminary 
experiments were therefore formulated to determine the M.L.D. of the 
stimulants used.
If the stimulant is a clear antagonist it would be reasonable to 
expect a reversal of narcosis or some evidences of stimulation at dosage 
levels slightly below or above the normal lethal figure.
Theoretically, the barbitalised animals ought to tolerate dosages 
of the stimulant agent in excess of the normal lethal figure ; the extent 
being a definite function of the degree of reciprocal antagonism. This 
was found to be the case in previous studies made on the comparative 
effectiveness of picrotoxin, strychnine, and cocaine in barbiturate 
intoxication [Maloney, 1933 a; Maloney, 1933 6], An animal poisoned 
with a barbiturate can tolerate, and recover from, a dose of picrotoxin, 
for example, which is many times lethal to a normal animal of the same 
species. Should death occur in such a case it is unmistakably a death 
from convulsions due to overdosage. If on the other hand the stimulant 
in question should happen to possess depressant properties, these 
properties would be expected to manifest themselves at some dosage 
level(s) short of their normal lethality by contributing to the death 
of the animal through addition, potentiation, or synergism to the 
depressant. Barring this latter assumption a sub-lethal dose of the 
stimulant administered to a depressed animal should not kill, and a 
lethal dose, if it proves fatal, should cause death in convulsions, or 
death as a sequel to convulsions.
R ats.
Experiments with Caffeine.—In determining the M.L.D. of caffeine 
for our rats, forty animals were employed. Doses of 200 mg. killed 
two out of ten. (All dosage figures in this paper represent milligrams 
per kilogram.) Doses of 300 mg., 400 mg., and 500 mg. proved 100 
per cent, fatal in each series. Caffeine in toxic doses does not cause 
death by convulsions but depression. The M.L.D. is about 250 mg.
Forty-eight rats were divided into four groups and the members of 
each group were given 200 mg. each of barbital subcutaneously. As 
soon as narcosis occurred caffeine was administered to the members of 
each group in series ranging from 100 mg. to 300 mg. Doses of 100 mg. 
were void of physiological effect. Optimal stimulation with temporary 
arousal was observed with doses of 150 mg. With a 200 mg. dosage 
100 per cent, became depressed after a brief period of stimulation; 
however, 60 per cent, recovered as against 80 per cent, which recovered 
from the same dose of caffeine alone. Doses of 300 mg. gave no evidences
of stimulation whatever; on the contrary 100 per cent, died in profound 
depression. Ten controls, all recovered from 200 mg. of barbital alone, 
and each animal was awake and apparently well earlier than those in 
the same group treated with caffeine. See Table I.
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T able  I .— Caffein e  on  R a t s .
Series.
Barbital,
mg./kg.
Caffeine,
mg./kg. Recovery. Remarks.
No. Animals.
1 8 200 100 8 Caffeine had no apparent effect on 
awakening time; no arousal.
2 20 150 20 Transitory arousal (five minutes 
±  )• One remained twenty-four 
hours in deep depression.
3 10 ” 200 6 Maj ority were aroused temporarily, gross tremors, all depressed; 
four died in depression.
4 10 300 0 No arousals, five died within five 
hours; two were dead next 
a .m . ; three died during the 
second night. All deaths oc­
curred in profound depression.
1 10 None M.L.D.
200
8 Apprehensive, gross tremors; stag­
gering gait; difficult breathing. 
Two died in depression on the 
following day.
2 10 300 0 Apprehensive, gross tremors; stag­
gering gait; difficult breathing. 
Between one hour and twenty- 
four hours after injection all died 
in depression.
3 10 >> 400 0 Practically same.
4 10 500 0 Practically same.
10 200 Controls 10 Four controls used in series No. 1 
and two in each of the three 
others. All recovered. Re­
covery time was earlier than 
that of treated animals in all 
series.
jExperiments with Coramine.—In determining the M.L.D. of coramine 
normal rats in series of ten each were given varying doses of the com­
pound. Those in series No. 1 received 200 mg. None showed con­
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vulsions, all suffered from fluid in the air passages, but all recovered. 
The members of series No. 2 received 300 mg. each. All went into 
severe convulsions and four died. Of the six that survived two developed 
respiratory disturbances following the accumulation of fluid in the air 
passages, and had to be sacrificed. Ten each in series No. 4 and 5 
received 400 and 500 mg. respectively. All died promptly in severe 
convulsions. We therefore place the M.L.D. for coramine at 350 mg.
Fifty-one rats each injected with 200 mg. of barbital were employed 
in studies on the effects of coramine. These were divided into five 
series, and given doses ranging from 150 to 500 mg. of coramine. The 
optimal dosage was 200 mg. This produced temporary arousal (average 
one hour) with no fatalities. Beyond this level temporary awakening 
occurred, but there were also convulsions of varying degrees of severity; 
60 per cent, died from 300 mg. Doses of 400 mg. and 500 mg. respect­
ively caused convulsions without arousal, followed by prolonged depres­
sion and 100 per cent, fatality.
With 300 mg. 60 per cent, of the rats used in the toxicity studies 
on coramine survived, whereas with the same dose administered to the 
previously barbitalised animals only 37-5 per cent, survived. See 
Table II.
The presence of fluid in the air passages following coramine alone, 
or in combination with the other pharmacodynamic agents here em­
ployed, was a constantly observed phenomenon in the rat. Mention 
of this has been made elsewhere [Maloney, 1934]. This appears to be 
a peculiar species reaction to coramine.
Experiments with Metrazol.—In determining the M.L.D. of metrazol 
ten normal rats were given 100 mg. doses of the compound sub­
cutaneously. Convulsions came on in a few minutes; six died. As a 
check ten were given 150 mg.; severe convulsions followed, and all 
were dead within fifteen minutes. The M.L.D. is about 100 mg.
Seventy rats grouped in eight series in our experiments with metrazol 
were given doses of 100, 150, 200, 300, 400, 500, 600, and 750 mg. respec­
tively in each series following the usual depressant doses of barbital. 
In series No. 1 with eight rats, and series No. 2 with five, the results were 
similar. No convulsions followed the administration of the metrazol 
doses, and all the animals were aroused and remained awake. In series 
No. 3 eight animals were employed. Metrazol (200 mg.) caused arousal 
followed by mild convulsions of brief duration, but all the animals 
survived and were apparently well after several minutes. Nine animals 
in series No. 6 received 500 mg. each. There were no clear convulsions, 
all animals were aroused, and seven remained awake while two reverted 
to a state of depression and died. Those that survived were rather 
listless, and showed a tardy recovery by comparison with the members 
of series No. 3. In series No. 8 each of ten animals received 750 mg. 
of metrazol. All immediately went into severe convulsions. Two
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T able  I I .— Coram ine  on  R a t s .
Series.
Barbital,
mg./kg.
Coramine,
mg./kg. Recovery. Remarks.
No. Animals.
1 8 200 150 8 No effect as compared with two 
controls.
2 7 200 7 Transitory arousal averaging one 
hour; no convulsions; fluid in 
air passages; complete recovery 
after a few days.
3 16 9 9 300 6 Transitory arousal averaging one 
hour; some had mild convul­
sions; ten died in depression; 
those surviving remained in pro­
longed depression; fluid in air 
passages.
4 10 99 400 0 All had mild convulsions; no arousals; after convulsions sub­
sided all passed into prolonged 
and profound depression.
5 10 9 9 500 0 Same.
1 10 None M.L.D.
200
10 Hyperexcitable; fluid in air pas­
sages; complete recovery after 
a few days.
2 10 9 9 300 6 All had severe convulsions; fluid 
in air passages and two devel­
oped respiratory disturbances; 
four died.
3 10 ” 400 0 All died in two hours from con­vulsions.
4 10 ” 500 0 Convulsions came on in twelve minutes; seven dead in fifteen 
minutes; all dead in twenty- 
five minutes.
10 200 Controls 10 Two controls used in each series. 
All recovered.
survived, but were sickly for two days before they were purposely 
sacrificed. See Table III.
This group of experiments supports Tartler’s [1929] conclusion that 
metrazol acts as a clear antagonist to barbital in the rat. The results 
of preliminary experiments, not reported, show that convulsions are
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T able  I I I .— Metrazol  on  R a t s .
Series. Animals. Barbital,mg./kg.
Metrazol,
mg./kg. Recovery. Remarks.
1 8 200 100 8 No convulsions; all animals were 
aroused and all remained awake.
2 5 - 150 5 Same.
3 8 ” 200 8 Arousal; hypersensitivity of brief duration; all well after several 
minutes.
4 10 9 9 300 10 All aroused; hypersensitive; mild 
convulsion; drowsy in two hours; 
9.00 a .m . next day all awake and 
well.
5 10 99 400 1 All aroused; hypersensitive; mild 
convulsion; shivers fourth hour; 
remain awake but inactive; 9.00 
a .m . next day all awake and well.
6 9 500 7 Hypersensitive; mild convulsions; 
all were aroused; seven stayed 
awake, two went into depression 
and died; those remaining awake 
were listless.
7 10 n 600 4 All aroused; hyperexcitable; one 
and one-half hours drowsy and 
losing equilibrium; two hours 
narcosis returned; five hours, 
one dead, nine in deep depres­
sion; 9.00 a .m . next day, five 
dead, four awake but sickly.
8 10 9 9 750 2 All were aroused; all convulsed 
severely; two survived but were 
sickly and weak for two days; 
purposely sacrificed.
1 10 None M.L.D.
100
4 Convulsions— severe; six died. 
This was the M.L.D.
2 10 a 150 0 Convulsions— severe; all ten 
were dead in fifteen minutes.
16 200 Controls 16 Two controls used in each series. 
All recovered.
produced by doses of 30 mg. with an optimal of 50 mg. in the normal 
rat. But the animal previously depressed with barbital is able to 
tolerate 100, 150, and even 200 mg. without (or with but very slight)
convulsive seizures and be aroused from depression. From such studies 
on the rat, therefore, one would conclude with Tartler [1929] that 
metrazol in contradistinction to coramine and caffeine is unequivocally 
stimulatory in action. It will be shown, however, that this conclusion 
does not hold true in studies on the rabbit.
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R abbits .
Experiments with Metrazol.— While the M.L.D. of metrazol for the 
rabbit was not determined we note from a previous study [Maloney 
and Tatum, 1932] that the dosages here employed are within the
T able  IV.— Metbazol  on  R a b b it s .
No. Series. Weight,
g-
Barbital,
mg./kg.
Metrazol,
mg./kg. Recovery. Remarks.
1 1 1290 150 25-1 Metrazol caused immediate 
arousal from narcosis; on 
foot; gradually begins to 
lose balance; returns to 
narcosis. Dead next morn­
ing.
2 » 1320 150 25-1 + Same.
3 2 2100 170 25-S + Metrazol caused immediate 
arousal; narcosis returns; 
awake next day. Diarrhoea 
and sniffles. Apparently 
well the third day.
4 > > 1400 >> 25-S + Same.
5 1650 25-S + Same.
6 3 2390 200 25, 12-5 
- I
+ Two fractional injections. 
Arousal follows each, but 
narcosis returns. Asleep 
next morning. Awoke 
during the day.
7 » 2420 * * 25, 20 - I
+ Same.
8 2160 9 9 25-1 + Same.
9 >> 2420 9 9 25-1 + Same.
10 ” 1795 200 14, 14 
- I
- Died during the night.
I =  Intravenous; S = Subcutaneous.
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sublethal range. Ten rabbits averaging 1900 g. were given barbital 
intraperitoneally in serial doses of 150, 170, or 200 mg. Upon the 
onset of narcosis metrazol in a 10 per cent, solution was administered.
T able  V .— Coram ine  on  R a b b it s .
No. Series. Weight,
g-
Barbital,
mg./kg.
Coramine,
mg./kg. Recovery. Remarks.
1 1 1090 150 80-1 Immediate increase in rate 
of respiration. Stands on 
feet but gradually returns 
to the narcotic state. Re­
mains in narcosis. Dead 
next morning.
2 >> 1100 >> 80-1 + Barbital depression was pro­
found. Coramine caused 
mild convulsions. Tem­
porary arousal. Narcosis. 
Awoke next day.
3 2 2000 170 80-S + Coramine caused temporary 
arousal. Narcosis re­
turned. Awoke next day. 
Sniffles and diarrhea, 
weak. Apparently well 
on second day.
4 ” 2100 80-S + Temporary arousal with return to sleep. Awake 
and well next morning.
5 ** 1500 >> 80-S + Same.
6 3 2460 200 50, 16, 25 
- I
+ Temporary arousal follow­
ing each injection of cor­
amine. Narcosis returns. 
Awoke next day. Well.
7 ** 2850 9 9 50, 16, 25 
- I
+ Same.
8 9 9 2310 50, 16, 25 
- I
Same.
9 i9 1560 53, 53, 53 
- I
+ Same.
I = Intravenous; S = Subcutaneous.
The animals in the 150 mg. series each received 25 mg. intravenously 
as a single dose. Their response was an immediate arousal, followed 
by a return to narcosis after a few minutes. Those in the 170 mg. 
series received 25 mg. of metrazol subcutaneously. The same type of
response was observed; but in addition the animals had diarrhoea and 
sniffles on the second day after permanent awakening. In the 200 mg. 
series two rabbits received 25 mg. intravenously as a single dose, and 
the phenomenon of temporary arousal was again observed. Thinking
Contradictory Actions of Caffeine, Coramine, and Metrazol 163
T able  VI.— R a bbit  Controls.
No. Series. Weight. Barbital, mg./'kg. Recovery. Remarks.
1 1 1200 150 + Barbital 5 per cent, solution injected 
intraperitoneally. Narcosis. Awak­
ening occurred during the night. 
Awake and well next morning.
2 2 3100 170 + Same.
3 » > 2100 a + Same.
4 3 2375 200 + Same.
5 > > 1755 t t + Same.
6 f j 1560 t t + Same.
7 1725 t t + Same.
8 Check 2700 Metrazol 
25 mg.-I
+ Normal animal injected with the 
stimulant intravenously as check on 
toxicity. Convulsions— not severe; 
well within one hour.
9 9 9 3500 Coramine 
80 mg.-I
+ Same.
I =  Intravenous.
that arousal might be made continuous by broken doses we gave one 
animal in the series two fractional injections of 14 mg. each, a second 
25 mg., and 12-5 mg. each, and a third 25 mg. and 20 mg. each. Arousal 
occurred immediately after each injection, the second lasting several 
hours. However, all the animals reverted to the state of narcosis, and 
were still asleep the next morning. Two animals died in depression 
the following day, one from the 150 mg. and one from the 200 mg. 
series. As an added check, one normal rabbit was given 25 mg. o f 
metrazol intravenously. Recovery followed the convulsive seizures. 
See Table IV.
Experiments with Coramine.—Nine rabbits were used in our study 
on coramine. The dosages of barbital were the same as those admin­
istered in the metrazol group. Two animals in the 150 mg. series 
received 80 mg. of coramine intravenously as a single dose; one
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recovered. The three in the 170 mg. series received each 80 mg. sub­
cutaneously; all recovered. The four animals in the 200 series received 
three fractional doses aggregating 91 mg., 91 mg., 91 mg., and 150 mg. 
respectively; all recovered. With each single or fractional injection 
in each group there was an immediate but transitory arousal. As an 
added check, one rabbit was given 80 mg. of coramine intravenously. 
Recovery followed the convulsive seizures. See Table V.
Seven animals were used as controls against the animals treated 
with coramine and metrazol respectively. These animals were given 
corresponding quantities of the standard doses of barbital alone. See 
Table VI. There were no fatalities as against two deaths in ten with 
barbital and metrazol, and one in nine with barbital and coramine.
It was interesting to observe that without a single exception the 
control animals all recovered from narcosis and were well earlier than 
every animal treated either with coramine or metrazol. Both coramine 
and metrazol, either as single sub-lethal doses or as fractional doses 
were effective in producing a transitory awakening; however, both re­
tarded the time of final awakening and complete recovery, and both 
caused a few fatalities as against 100 per cent, recoveries with the 
untreated controls.
D iscussion.
The fact that certain pharmacodynamic agents exert contradictory 
actions is generally recognised. Claude Bernard [1864] was the first 
to attribute excitatory as well as soporific properties to morphine, 
having noted signs of increased irritability in animals subjected to large 
subcutaneous doses of the alkaloid. Since that time several investi­
gators, notably Tatum, Seevers, and Collins [1929] have convincingly 
demonstrated this phenomenon. Heubner and Loewe [1913] were 
among the first to note the stimulant-depressant properties of strychnine. 
They attributed strychnine paralysis to the action of its constituent 
depressant principle. Several hypnotics—paraldehyde, chloral hydrate, 
barbiturates, etc.—under suitable conditions, manifest the contradictory 
phenomena of narcosis and motor hyperexcitability. Silver [1930] 
divided this motor excitability into two components (a) response to 
pain, and (b) somatic irritability. Using the pernoctonised rabbit, he 
found that caffeine, coramine, metrazol, and other cortical stimulants 
acted similar to morphine in abolishing the reflex response to pain, 
but whereas morphine at the same time abolished somatic excitability 
the stimulant drugs accentuated it. Tartler [1929], using small doses 
of medinal (barbital-sodium) on the rat, noted varying degrees of reversal 
as well as accentuation of its narcotic action with caffeine, hexetone, 
and coramine.
The results of these experiments confirm us in the view that, in 
addition to their stimulatory properties, caffeine, coramine, and metrazol
are possessed of subsidiary depressant properties which serve to accent­
uate an already existing state of depression under certain disturbed 
physico-chemical conditions. As such they are contraindicated in 
conditions of profound barbiturate intoxication. These compounds, 
like strychnine [Barlow, 1932; Maloney, Fitch, and Tatum, 1931], may 
hasten respiratory paralysis.
A simple case of mild hyposensitivity may respond to any ordinary 
primary stimulant, but deep depression such as would result from the 
taking of large doses of a barbiturate with suicidal intent calls for a 
therapeutic agent possessing unequivocal antidotal potentiality. For 
such a state we have found picrotoxin the antidote of first choice.
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Sum m ary .
The results of experiments on rats and rabbits narcotised with 
barbital and treated with caffeine, coramine, or metrazol reveal the 
fact that these substances are capable of accentuating the depressant 
action of the barbiturate under certain conditions.
The barbiturate was administered in single sub-lethal doses. The 
other substances were given in varying quantities, each dosage unit 
being slightly below or above the lethal level for normal controls.
Sub-lethal doses of caffeine and coramine administered to the 
barbitalised rat caused transient arousals, with tremors or mild con­
vulsions at certain dosage levels and the same effects, followed by 
delayed death in depression, at higher levels. The percentage of re­
coveries from the combined substances was less than that from caffeine 
and coramine alone.
Lethal doses of metrazol caused permanent arousal without con­
vulsions at lower dosage levels, permanent arousal with convulsions at 
higher levels, and convulsions followed by death at still higher levels. 
The barbitalised rat was able to tolerate large lethal doses of metrazol, 
indicating a high degree of reciprocal antagonism between barbital and 
metrazol in that species.
A depressant effect was more in evidence than a stimulatory action 
with caffeine.
The rat manifests a distinct species intolerance to coramine. It is 
not a suitable animal on which to make generalisations in comparative 
studies on coramine.
Normally stimulating doses of coramine and metrazol, administered 
in single or fractional portions to barbitalised rabbits, caused transitory 
arousal at certain dosage levels, with death in depression in others; 
but in every instance coramine or metrazol, when combined with barbital, 
increased the duration of narcosis over that of the controls, and caused 
some fatalities.
These studies point to possible danger in the use of these substances
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indiscriminately in barbiturate depression and emphasise their contra­
indication in deep barbiturate depression.
We interpret these phenomena as due to a secondary depressant 
action of caffeine, coramine, and metrazol elicited at certain levels of 
depression initiated by the barbiturates.
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